FDA clears Qure.ai ' s tuberculosis software

Medical imaging AI company Qure.ai has secured breakthrough device designation from the U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) for its tuberculosis software, qSpot-TB.

Source: AuntMinnie.com Headlines - February 5, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news